Additionally, the study’s findings on the interplay between TGF-β1 and systemic inflammatory markers, such as the neutrophil-to-lymphocyte ratio, further emphasize the complex microenvironmental interactions influencing bladder cancer outcomes. The gene discussed is TGFB1; the disease is urinary bladder carcinoma.